Principal Financial Group Inc Verona Pharma PLC Transaction History
Principal Financial Group Inc
- $184 Billion
- Q3 2025
A detailed history of Principal Financial Group Inc transactions in Verona Pharma PLC stock. As of the latest transaction made, Principal Financial Group Inc holds 21,364 shares of VRNA stock, worth $2.28 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,364
Previous 21,364
-0.0%
Holding current value
$2.28 Million
Previous $2.02 Million
12.82%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
239Shares Held
78.3MCall Options Held
686KPut Options Held
442K-
Pentwater Capital Management LP Naples, FL5.3MShares$567 Million3.55% of portfolio
-
Ubs Oconnor LLC Chicago, IL4.28MShares$458 Million27.57% of portfolio
-
Hbk Investments L P Dallas, TX4.26MShares$456 Million6.29% of portfolio
-
Fil LTD Hamilton, D03.49MShares$373 Million0.32% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$362 Million15.27% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.52B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...